Xenotransplantation Model of Psoriasis

  • Jeremy Di Domizio
  • Curdin Conrad
  • Michel Gilliet
Part of the Methods in Molecular Biology book series (MIMB, volume 1559)


Psoriasis is a chronic autoimmune skin disease affecting approximately 2 % of the population with a major psychosocial and socioeconomic impact. A causal therapy leading to permanent cure is not available, and current treatments only lead to limited amelioration, and therefore new therapeutic targets need to be identified. Recent works demonstrated a predominant role of TH17 cells in the pathogenesis of psoriasis; yet the underlying molecular mechanisms driving the development of the disease are still largely elusive. Several mouse models of psoriasis including drug-induced models (topical application of imiquimod to the skin) and genetically engineered mice (constitutive activation of epidermal STAT3, epidermal deletion of JunB/c-Jun, and epidermal overexpression of Tie2) have been used to study the pathophysiology of the disease; however such models cannot fully recapitulate all molecular and cellular pathways occurring in human psoriasis. Xenotransplantation of human pre-psoriatic skin onto immunodeficient mice and triggering its conversion into a psoriatic plaque is the best model to dissect the mechanisms occurring during the development of human psoriasis. One model is based on the transplantation of human pre-psoriatic skin onto SCID mice followed by the transfer of activated autologous T cells. The ex vivo activation of T cells required to induce the psoriatic conversion of the graft limits the study of early events in the pathogenesis of psoriasis. Another model is based on transplantation of human pre-psoriatic skin onto AGR129 mice. In this model, the skin grafting is sufficient to activate human cells contained in the graft and trigger the conversion of the graft into a psoriatic skin, without the need of transferring activated T cells. Here we review the methodological aspects of this model and illustrate how this model can be used to dissect early events of psoriasis pathogenesis.

Key words

Preclinical model Psoriasis Xenotransplant 


  1. 1.
    Gaffen SL, Jain R, Garg AV, Cua DJ (2014) The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14(9):585–600CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD et al (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182(9):5836–5845CrossRefPubMedGoogle Scholar
  3. 3.
    Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201(2):233–240CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD et al (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8(9):950–957CrossRefPubMedGoogle Scholar
  5. 5.
    Manel N, Unutmaz D, Littman DR (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9(6):641–649CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Bettelli E, Korn T, Oukka M, Kuchroo VK (2008) Induction and effector functions of T(H)17 cells. Nature 453(7198):1051–1057CrossRefPubMedGoogle Scholar
  7. 7.
    Donnelly RP, Sheikh F, Dickensheets H, Savan R, Young HA, Walter MR (2010) Interleukin-26: an IL-10-related cytokine produced by Th17 cells. Cytokine Growth Factor Rev 21(5):393–401CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P et al (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194(4):519–527CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wolk K, Witte E, Witte K, Warszawska K, Sabat R (2010) Biology of interleukin-22. Semin Immunopathol 32(1):17–31CrossRefPubMedGoogle Scholar
  10. 10.
    Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S et al (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118(2):597–607PubMedPubMedCentralGoogle Scholar
  11. 11.
    Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L et al (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448(7152):480–483CrossRefPubMedGoogle Scholar
  12. 12.
    Swindell WR, Johnston A, Carbajal S, Han G, Wohn C, Lu J et al (2011) Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One 6(4):e18266CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Nickoloff BJ, Wrone-Smith T (1999) Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 155(1):145–158CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO (2004) Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 199(5):731–736CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O et al (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202(1):135–143CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Conrad C, Boyman O, Tonel G, Tun-Kyi A, Laggner U, de Fougerolles A et al (2007) Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med 13(7):836–842CrossRefPubMedGoogle Scholar
  17. 17.
    Gaide O, Emerson RO, Jiang X, Gulati N, Nizza S, Desmarais C et al (2015) Common clonal origin of central and resident memory T cells following skin immunization. Nat Med 21(6):647–653CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Tonel G, Conrad C, Laggner U, Di Meglio P, Grys K, McClanahan TK et al (2010) Cutting edge: a critical functional role for IL-23 in psoriasis. J Immunol 185(10):5688–5691CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Di Meglio P, Villanova F, Navarini AA, Mylonas A, Tosi I, Nestle FO, Conrad C (2016) Targeting CD8(+) T cells prevents psoriasis development. J Allergy Clin Immunol 138(1):274–276.e6Google Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  • Jeremy Di Domizio
    • 1
  • Curdin Conrad
    • 1
  • Michel Gilliet
    • 1
  1. 1.Department of DermatologyUniversity Hospital CHUVLausanneSwitzerland

Personalised recommendations